© copyright 2002 frost & sullivan. all rights reserved. u.s. anticoagulant and antiplatelet...
DESCRIPTION
© Copyright 2002 Frost & Sullivan. All Rights Reserved. Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans What We OfferTRANSCRIPT
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
U.S. Anticoagulant and Antiplatelet Therapies Markets
New Generation Therapies Signify Market Growth
"The growing patient uptake of innovative and costly anticoagulants and antiplatelets coupled with the exploration of opportunities in under-served, niche markets, drive the
growth of the anti-clotting therapies market in the United States.”
Pharmaceutical Biotech Analyst Team
Frost & Sullivan
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Frost & Sullivan provides: • Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analyst insights on ‘hot topics’ and emerging applications in the anticoagulant and antiplatelet therapies market
• Market sizing and competitive analysis
• Market forecasts and opportunity analysis
• Quarterly assessments
• End user analysis within each report
Key Features
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
• Coverage: The United States
• Proven methodology encompassing extensive primary and secondary data and research
• Focused information and strategies that cover business and technology issues
• Credible data and analysis highlighting industry dynamics
• Winning strategies to help you create precise business plans
What We Offer
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Current Market Participants• Find out how you compare to the competition• Assess current and future drivers and restraints• Determine and exploit new market share opportunities
New Entrants • Analyze challenges associated with the industry• Calculate time scales for strategy implementation• Position yourself to capitalize on the market’s unmet needs
Investment Community• Analyze long-term strategies of companies• Determine which participants will outperform the competition• Assess attractiveness of investing in the market
Who Will Benefit?
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
3-Dimensional Pharmaceuticals, Inc.Abbott LaboratoriesAkzo Nobel nvAmerican Biogenetic SciencesAmerican Heart Association, Inc.AstraZeneca Pharmaceuticals LPAventis Pharmaceuticals, Inc.Berlex Laboratories, Inc.Boehringer Ingelheim Pharmaceuticals, Inc.Bristol-Myers Squibb Co.Centocor, Inc.Corvas International, Inc.Eli Lilly & Co.Emisphere Technologies, Inc.Eon Laboratories, Inc.
GlaxoSmithKlineGlycoDesign, Inc.La Jolla Pharmaceutical Co.Merck & Co.Millennium Pharmaceuticals, Inc.Mitsubishi Pharma America, Inc.Par Pharmaceutical, Inc.Pharmacia Corp.Roche PharmaceuticalsSanofi-Synthelabo, Inc.Schering-Plough Corp.Taro Pharmaceuticals USA, Inc.Texas Biotechnology Corp.The Medicines Co.Yamanouchi Pharma America, Inc.
Key Market Participants
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
• Call toll free 877 GO FROST (877.463.7876)
• Fax toll free 888.690.3329
• E-mail [email protected]
• Visit www.frost.com
For More Information